Beneficient Form 8-K Summary
Business Context and Reporting Period
Beneficient filed a Current Report on Form 8-K dated November 28, 2023, reporting a Nasdaq continued-listing deficiency involving its Class A common stock. The report was signed and filed on December 1, 2023.
Financial Metrics and Liquidity
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating or financial metrics.
Material Change Versus Prior Period
On November 28, 2023, Nasdaq notified Beneficient that the closing bid price of its Class A common stock had remained below the required minimum of $1.00 per share for 30 consecutive business days. The stock continued to trade on the Nasdaq Global Market under the symbol BENF, and the notice had no immediate effect on its listing.
Guidance, Risks, Contingencies, and Unusual Items
- Beneficient received an initial 180-calendar-day compliance period ending May 28, 2024.
- The company may regain compliance if its bid price closes at $1.00 or more for at least 10 consecutive business days, subject to Nasdaq’s discretion to extend or require a longer period.
- If it does not regain compliance by May 28, 2024, Beneficient may qualify for a second 180-day compliance period by transferring its listing to the Nasdaq Capital Market and satisfying applicable requirements other than the bid-price requirement.
- Failure to regain compliance could result in a delisting notice. The company would have appeal rights, but there is no assurance that an appeal would succeed.
- Management is monitoring the stock price and evaluating actions, including a possible reverse stock split, to restore compliance. No assurance was provided that compliance will be regained.
- Risks include failure to satisfy Nasdaq requirements, ineligibility for additional compliance periods, costs and management distraction, and potential delisting.
Investor Verification Items
- Verify whether Beneficient regained compliance by the May 28, 2024 deadline or obtained an additional compliance period.
- Check for any subsequent Nasdaq delisting notice, appeal, listing transfer, or reverse stock split.
- Review subsequent SEC filings for the effect of the listing deficiency on trading, financing access, shareholder value, and corporate operations.
- Confirm that the Class A common stock and related warrants remain listed and actively trading on Nasdaq.